Twist Bioscience Corp
NASDAQ:TWST
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24.02
58.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TWST stock under the Base Case scenario is 57.02 USD. Compared to the current market price of 42.23 USD, Twist Bioscience Corp is Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Twist Bioscience Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TWST cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Twist Bioscience Corp
Balance Sheet Decomposition
Twist Bioscience Corp
Current Assets | 346.8m |
Cash & Short-Term Investments | 276.4m |
Receivables | 34.9m |
Other Current Assets | 35.5m |
Non-Current Assets | 267.5m |
PP&E | 161.3m |
Intangibles | 100.3m |
Other Non-Current Assets | 5.9m |
Current Liabilities | 71m |
Accounts Payable | 1.6m |
Accrued Liabilities | 63.6m |
Other Current Liabilities | 5.8m |
Non-Current Liabilities | 70.6m |
Other Non-Current Liabilities | 70.6m |
Earnings Waterfall
Twist Bioscience Corp
Revenue
|
313m
USD
|
Cost of Revenue
|
-179.6m
USD
|
Gross Profit
|
133.3m
USD
|
Operating Expenses
|
-309.3m
USD
|
Operating Income
|
-175.9m
USD
|
Other Expenses
|
-32.8m
USD
|
Net Income
|
-208.7m
USD
|
Free Cash Flow Analysis
Twist Bioscience Corp
USD | |
Free Cash Flow | USD |
TWST Profitability Score
Profitability Due Diligence
Twist Bioscience Corp's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Twist Bioscience Corp's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
TWST Solvency Score
Solvency Due Diligence
Twist Bioscience Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Twist Bioscience Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TWST Price Targets Summary
Twist Bioscience Corp
According to Wall Street analysts, the average 1-year price target for TWST is 54.25 USD with a low forecast of 48.38 USD and a high forecast of 65.1 USD.
Dividends
Current shareholder yield for TWST is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
TWST Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 652 full-time employees. The company went IPO on 2018-10-31. The firm has developed a Twist Bioscience DNA synthesis platform to industrialize the engineering of biology. The core of its platform is a technology that provides a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. The firm has developed multiple products derived from synthetic DNA and its versatile DNA synthesis technology. The company consists of two product lines, synthetic biology tools and NGS tools, that address different needs of its customers across a range of applications, such as synthetic genes, oligo pools, SARS-CoV-2 tools, and DNA libraries. Its synthetic biology products include Synthetic genes, Clonal genes in a Twist Bioscience, Non-clonal genes, Oligonucleotide or Oligo, pools, and Oligo pools for CRISPR gene editing. The NGS products are used for diagnostic tests for various indications like SARS-CoV-2 and cancer through liquid biopsy.
Contact
IPO
Employees
Officers
The intrinsic value of one TWST stock under the Base Case scenario is 57.02 USD.
Compared to the current market price of 42.23 USD, Twist Bioscience Corp is Undervalued by 26%.